We have previously reported that while activin and TGF-β share canonical signaling, in CRC they diverge in their non-canonical pathways with activin primarily signaling through PI3K/AKT while TGF-β activates MAP/ERK13. Here, TGFB1 is linked to colorectal carcinoma.